Partially biodegradable PE/PHA blends for sustainable packaging
Introducing a partially biodegradable resin system combining PE and PHA for injection-molded packaging. This innovative blend aims to balance biodegradability with mechanical strength, offering a transitional solution toward fully sustainable packaging materials.
Overview
The proposed technology focuses on developing a partially biodegradable resin system by blending polyethylene (PE) with polyhydroxyalkanoates (PHA). This innovation aims to address the current gap in fully biodegradable injection-moldable materials that meet commercial requirements. By treating these blends as micromechanical systems, the research explores how immiscibility, crystallization kinetics, and interfacial structures influence mechanical strength, melt flow, and biodegradability. This approach seeks to establish design rules for creating lower-impact packaging alternatives that are both functionally effective and environmentally responsible.
Technical specifications
Key features:
- Combines PE for processing reliability with PHA for biodegradability
- Evaluates crystallization behavior under injection molding conditions
- Assesses rheological properties through shear- and temperature-dependent tests
- Links material morphology to mechanical strength and ductility
- Investigates disintegration behavior in composting and aqueous environments to mitigate microplastic risks
Technology readiness level
The current research is at Technology Readiness Level 3, indicating an experimental proof of concept. The focus is on systematically blending PE and PHA, characterizing their crystallization and mechanical properties, and evaluating their environmental disintegration. Further validation will be conducted to refine the blends and optimize their performance for commercial applications.
About University of British Columbia
UBC is a comprehensive public research university with major campuses in Vancouver and the Okanagan, among Canada’s largest and most internationally connected. Industry engages through a co-op talent pipeline and collaborative research spaces that include co-located clinical settings and on‑campus testbeds. A dedicated technology transfer office brokers partnerships, manages IP and licensing, and is complemented by an active venture accelerator and incubator network. Research is supported by competitive funding from Canada’s Tri‑Council agencies (NSERC, CIHR, SSHRC) and infrastructure investments from the Canada Foundation for Innovation, alongside provincial and industry sponsorship.
delivered to your inbox.